Toyoaki Murohara

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Angiotensin Converting Enzyme

Arterial Hypertension

Top Venues

Heart failure reviews

American journal of cardiovascular drugs : drugs, devices, and other interventions

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Katsumi Miyauchi, Hiroshi Iwata, Yuji Nishizaki, Teruo Inoue, Atsushi Hirayama, Kazuo Kimura, Yukio Ozaki, Toyoaki Murohara, Kenji Ueshima, Yoshihiro Kuwabara, Sachiko Tanaka-Mizuno, Naotake Yanagisawa, Tosiya Sato, Hiroyuki Daida, null null
Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (3) (2024)
Hiroaki Hiraiwa, Daisuke Kasugai, Takahiro Okumura, Toyoaki Murohara
Clinical implications of septic cardiomyopathy: A narrative review. Medicine 103 (17) (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (3) (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Satoya Yoshida, Tatsuya Yoshida, Kohei Inukai, Katsuhiro Kato, Yoshimitsu Yura, Tomoki Hattori, Atsushi Enomoto, Koji Ohashi, Takahiro Okumura, Noriyuki Ouchi, Haruya Kawase, Nina Wettschureck, Stefan Offermanns, Toyoaki Murohara, Mikito Takefuji
Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion. Nature communications 15 (1) (2024)
Hiroaki Hiraiwa, Daisuke Kasugai, Takahiro Okumura, Toyoaki Murohara
Clinical implications of septic cardiomyopathy: A narrative review. Medicine 103 (17) (2024)
Naoya Inoue, Shuji Morikawa, Takashi Ogane, Takehiro Hiramatsu, Toyoaki Murohara
Clinical value of the fibrosis-4 index in predicting mortality in patients with right ventricular pacing. PloS one 19 (2) (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (3) (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (3) (2024)
Hiroaki Hiraiwa, Daisuke Kasugai, Takahiro Okumura, Toyoaki Murohara
Clinical implications of septic cardiomyopathy: A narrative review. Medicine 103 (17) (2024)
Katsumi Miyauchi, Hiroshi Iwata, Yuji Nishizaki, Teruo Inoue, Atsushi Hirayama, Kazuo Kimura, Yukio Ozaki, Toyoaki Murohara, Kenji Ueshima, Yoshihiro Kuwabara, Sachiko Tanaka-Mizuno, Naotake Yanagisawa, Tosiya Sato, Hiroyuki Daida, null null
Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation 150 (6) (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Naoya Inoue, Shuji Morikawa, Takashi Ogane, Takehiro Hiramatsu, Toyoaki Murohara
Clinical value of the fibrosis-4 index in predicting mortality in patients with right ventricular pacing. PloS one 19 (2) (2024)
Shin Nagai, Hiroaki Hiraiwa, Ryota Ito, Yuichiro Koyama, Kiyota Kondo, Shingo Kazama, Toru Kondo, Ryota Morimoto, Takahiro Okumura, Hideki Ito, Tomo Yoshizumi, Masato Mutsuga, Toyoaki Murohara
Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (2024)
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (3) (2024)
Kazuya Hosokawa, Hiroko Watanabe, Yu Taniguchi, Nobutaka Ikeda, Takumi Inami, Satoshi Yasuda, Toyoaki Murohara, Masaru Hatano, Yuichi Tamura, Jun Yamashita, Koichiro Tatsumi, Ichizo Tsujino, Yuko Kobayakawa, Shiro Adachi, Nobuhiro Yaoita, Shun Minatsuki, Koji Todaka, Keiichi Fukuda, Hiroyuki Tsutsui, Kohtaro Abe, null null
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial. Circulation (2023)
Yuta Ozaki, Koji Ohashi, Naoya Otaka, Hiroshi Kawanishi, Tomonobu Takikawa, Lixin Fang, Kunihiko Takahara, Minako Tatsumi, Sohta Ishihama, Mikito Takefuji, Katsuhiro Kato, Yuuki Shimizu, Yasuko K Bando, Aiko Inoue, Masafumi Kuzuya, Shinji Miura, Toyoaki Murohara, Noriyuki Ouchi
Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway. Nature communications 14 (1) (2023)
Hiroaki Hiraiwa, Daisuke Kasugai, Takahiro Okumura, Toyoaki Murohara
Implications of uremic cardiomyopathy for the practicing clinician: an educational review. Heart failure reviews (2023)
Toru Kondo, Takuji Adachi, Kiyonori Kobayashi, Takahiro Okumura, Hideo Izawa, Toyoaki Murohara, John Joseph Valentine McMurray, Sumio Yamada
Physical Frailty and Use of Guideline-Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction. Journal of the American Heart Association (2023)
Junya Suzuki, Yuuki Shimizu, Takumi Hayashi, Yiyang Che, Zhongyue Pu, Kazuhito Tsuzuki, Shingo Narita, Rei Shibata, Isao Ishii, John W Calvert, Toyoaki Murohara
Hydrogen Sulfide Attenuates Lymphedema Via the Induction of Lymphangiogenesis Through a PI3K/Akt-Dependent Mechanism. Journal of the American Heart Association 11 (21) (2022)
Toru Kondo, Takahiro Okumura, Naoki Shibata, Takahiro Imaizumi, Kaoru Dohi, Hideo Izawa, Nobuyuki Ohte, Tetsuya Amano, Toyoaki Murohara
Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study. Journal of the American Heart Association 11 (4) (2022)
Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa, Nobukazu Ishizaka, Yumiko Kanzaki, Hirofumi Tomiyama, Masataka Sata, Akira Sezai, Kazuo Eguchi, Toru Kato, Shigeru Toyoda, Ryoichi Ishibashi, Kazuomi Kario, Tomoko Ishizu, Shinichiro Ueda, Koji Maemura, Yukihito Higashi, Hirotsugu Yamada, Mitsuru Ohishi, Kotaro Yokote, Toyoaki Murohara, Jun-Ichi Oyama, Koichi Node, null null
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial. PLoS medicine 17 (4) (2020)